FORM OF [SERIES A/SERIES B] ORDINARY SHARE PURCHASE WARRANT Vascular Biogenics Ltd.Vascular Biogenics Ltd. • June 27th, 2018 • Pharmaceutical preparations
THIS [SERIES A/SERIES B] ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Vascular Biogenics Ltd., a company organized under the laws of Israel (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Ordinary Shares, NIS 0.01 par value (the “Ordinary Share(s)”), of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Form of SECURITIES PURCHASE AGREEMENTForm of Securities Purchase Agreement • June 27th, 2018 • Vascular Biogenics Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 25, 2018, between Vascular Biogenics Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
